Therapy Optimization in Multiple Sclerosis
- Study Title
- Therapy Optimization in Multiple Sclerosis (MS)
- Teva Identifier
- PM032
- ClinicalTrials.gov Identifier
- NCT00819000
- Study Status
- Completed
- Trial Condition(s)
- Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 12/01/2008 - 01/01/2013
